Clearmind Medicine (CMND) vs Silexion Therapeutics (SLXN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Silexion Therapeutics is the larger company by market cap ($3.4 million vs $3.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CMND | SLXN |
|---|---|---|
| Share price | $6.60 | $0.2349 |
| Market cap | $3.35M | $3.40M |
| 1-day change | 0.00% | -7.37% |
| EPS (TTM) | $-461.20 | $-27.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3,840.00 | $40.70 |
| 52-week low | $5.25 | $0.222 |
| Distance from 52-week high | -99.83% | -99.42% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +2028.57% |
| Average volume | 70.89K | 9.90M |
| Shares outstanding | 507.40K | 14.47M |
| Employees | — | 13 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Clearmind Medicine
CMND stock →Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression.
Health Care · Biotechnology: Pharmaceutical Preparations
About Silexion Therapeutics
SLXN stock →Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 13 employees
CMND vs SLXN FAQ
Which is bigger, Clearmind Medicine or Silexion Therapeutics?
Silexion Therapeutics (SLXN) is larger, with a market capitalization of $3.40M compared with $3.35M for Clearmind Medicine (CMND).
Are Clearmind Medicine and Silexion Therapeutics in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Clearmind Medicine and Biotechnology: Biological Products (No Diagnostic Substances) for Silexion Therapeutics.